275 related articles for article (PubMed ID: 3237310)
21. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
22. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cholinergic muscarinic receptors in the rabbit iris.
Honkanen RE; Abdel-Latif AA
Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
[TBL] [Abstract][Full Text] [Related]
24. Regulation of muscarinic receptors by intrahippocampal injections of gallamine.
Messer WS; Ellerbrock BR; Bohnett M
Brain Res; 1991 Nov; 564(1):73-8. PubMed ID: 1777823
[TBL] [Abstract][Full Text] [Related]
25. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
Lee NH; el-Fakahany EE
J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
[TBL] [Abstract][Full Text] [Related]
26. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
Lee JH; el-Fakahany EE
Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
[TBL] [Abstract][Full Text] [Related]
27. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
28. PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.
Michel AD; Stefanich E; Whiting RL
Br J Pharmacol; 1989 Jul; 97(3):914-20. PubMed ID: 2758243
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
30. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the interactions of gallamine with muscarinic receptors from brain.
Ellis J; Lenox RH
Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
[No Abstract] [Full Text] [Related]
32. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
33. [3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: characterization, localization on T-lymphocyte subsets and age-dependent changes.
Eva C; Ferrero P; Rocca P; Funaro A; Bergamasco B; Ravizza L; Genazzani E
Neuropharmacology; 1989 Jul; 28(7):719-26. PubMed ID: 2788247
[TBL] [Abstract][Full Text] [Related]
34. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
35. Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin.
Larocca JN; Ledeen RW; Dvorkin B; Makman MH
J Neurosci; 1987 Dec; 7(12):3869-76. PubMed ID: 3694257
[TBL] [Abstract][Full Text] [Related]
36. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
Cortés R; Palacios JM
Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
[TBL] [Abstract][Full Text] [Related]
37. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
Wreggett KA; Wells JW
J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
[TBL] [Abstract][Full Text] [Related]
38. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
Ellis J; Seidenberg M; Brann MR
Mol Pharmacol; 1993 Sep; 44(3):583-8. PubMed ID: 7690450
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
40. Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment.
Cioffi CL; el-Fakahany EE
Eur J Pharmacol; 1988 Oct; 156(1):35-45. PubMed ID: 2850209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
